Exact Mass: 283.1743502

Exact Mass Matches: 283.1743502

Found 279 metabolites which its exact mass value is equals to given mass value 283.1743502, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Metolachlor

2-chloro-N-(2-ethyl-6-methylphenyl)-N-(1-methoxypropan-2-yl)acetamide

C15H22ClNO2 (283.1338982)


CONFIDENCE standard compound; INTERNAL_ID 988; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9405; ORIGINAL_PRECURSOR_SCAN_NO 9403 CONFIDENCE standard compound; INTERNAL_ID 988; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9416; ORIGINAL_PRECURSOR_SCAN_NO 9412 CONFIDENCE standard compound; INTERNAL_ID 988; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9435; ORIGINAL_PRECURSOR_SCAN_NO 9432 CONFIDENCE standard compound; INTERNAL_ID 988; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9411; ORIGINAL_PRECURSOR_SCAN_NO 9409 CONFIDENCE standard compound; INTERNAL_ID 988; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9432; ORIGINAL_PRECURSOR_SCAN_NO 9430 CONFIDENCE standard compound; INTERNAL_ID 988; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9555; ORIGINAL_PRECURSOR_SCAN_NO 9554 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1082 CONFIDENCE standard compound; EAWAG_UCHEM_ID 268 CONFIDENCE standard compound; INTERNAL_ID 4040 CONFIDENCE standard compound; INTERNAL_ID 8418 CONFIDENCE standard compound; INTERNAL_ID 3556 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Levallorphan

(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-4-ol

C19H25NO (283.193604)


An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Amabiline

(7aS)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-ylmethyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO4 (283.178349)


Amabiline belongs to alkaloids and derivatives class of compounds. Those are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic propertiesand is also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Amabiline is soluble (in water) and a very weakly acidic compound (based on its pKa). Amabiline can be found in borage, which makes amabiline a potential biomarker for the consumption of this food product.

   

Histrionicotoxin

(2S,6R,10S,11S)-11-[(E)-but-1-en-3-ynyl]-2-[(E)-pent-2-en-4-ynyl]-1-azaspiro[5.5]undecan-10-ol

C19H25NO (283.193604)


An azaspiro compound that is 1-azaspiro[5.5]undecane substituted by a hydroxy group at position 8, a but-1-en-3-yn-1-yl group at position 7 and a pent-3-en-1-yn-5-yl group at position 2 (the 2S,6R,7S,8S stereoisomer).

   

Delachlor

Acetamide,2-chloro-N-(2,6-dimethylphenyl)-N-[(2-methylpropoxy)methyl]-

C15H22ClNO2 (283.1338982)


   

brevianamide F

brevianamide F

C16H17N3O2 (283.1320702)


A pyrrolopyrazine that is hexahydropyrrolo[1,2-a]pyrazine-1,4-dione bearing an indol-3-ylmethyl substituent at position 3 (the 3S,8aS-diastereomer, obtained by formal cyclocondensation of L-tryptophan and L-proline). Brevianamide F (Cyclo(L-Pro-L-Trp)) is a mycotoxin isolated from Colletotrichum gloeosporioides, with antibacterial activity. Brevianamide F shows potent PI3Kα inhibitory activity with an IC50 of 4.8 μM[1][2].

   

Supinine

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl ester, (7aS-(7(2R*,3S*),7aR*))-

C15H25NO4 (283.178349)


Supinine is also known as spinin. Supinine is soluble (in water) and a very weakly acidic compound (based on its pKa). Supinine can be found in borage, which makes supinine a potential biomarker for the consumption of this food product.

   

alpha-Hydroxymetoprolol

1-[4-(1-hydroxy-2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol

C15H25NO4 (283.178349)


alpha-Hydroxymetoprolol is a metabolite of metoprolol. Metoprolol is a selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension. The active substance metoprolol is employed either as metoprolol succinate or metoprolol tartrate (where 100 mg metoprolol tartrate corresponds to 95 mg metoprolol succinate). The tartrate is an immediate-release and the succinate is an extended-release formulation. (Wikipedia)

   

Lysylhistidine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-5-yl)propanoic acid

C12H21N5O3 (283.16443160000006)


Lysylhistidine is a dipeptide composed of lysine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaminylhistidine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-(3H-imidazol-4-yl)propanoic acid

C11H17N5O4 (283.1280482)


Glutaminylhistidine is a dipeptide composed of glutamine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Histidylglutamine

(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C11H17N5O4 (283.1280482)


Histidylglutamine is a dipeptide composed of histidine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Histidyllysine

(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C12H21N5O3 (283.16443160000006)


Histidyllysine is a dipeptide composed of histidine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

N-Dealkylated tolterodine

4-methyl-2-[(1R)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.193604)


N-Dealkylated tolterodine is only found in individuals that have used or taken tolterodine. N-Dealkylated tolterodine is a metabolite of tolterodine. N-Dealkylated tolterodine belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.

   

Histidinyl-Gamma-glutamate

2-Amino-4-{[2-amino-3-(1H-imidazol-5-yl)propanoyl]-C-hydroxycarbonimidoyl}butanoate

C11H17N5O4 (283.1280482)


Histidinyl-Gamma-glutamate is a dipeptide composed of histidine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Cadralazine

N-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}ethoxycarbohydrazonic acid

C12H21N5O3 (283.16443160000006)


C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DB - Hydrazinophthalazine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class. D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Octa-2,6-dienoylcarnitine

3-(octa-2,6-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C15H25NO4 (283.178349)


octa-2,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an octa-2,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-2,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-2,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-3,6-dienoylcarnitine

3-(octa-3,6-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C15H25NO4 (283.178349)


octa-3,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an octa-3,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-3,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-3,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,6Z)-Octa-4,6-dienoylcarnitine

3-(octa-4,6-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C15H25NO4 (283.178349)


(4Z,6Z)-octa-4,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,6Z)-octa-4,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,6Z)-octa-4,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4Z,6Z)-octa-4,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-2,5-dienoylcarnitine

3-(octa-2,5-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C15H25NO4 (283.178349)


octa-2,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an octa-2,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-2,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-2,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-2,4-dienoylcarnitine

3-(octa-2,4-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C15H25NO4 (283.178349)


octa-2,4-dienoylcarnitine is an acylcarnitine. More specifically, it is an octa-2,4-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-2,4-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-2,4-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-3,5-dienoylcarnitine

3-(octa-3,5-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C15H25NO4 (283.178349)


octa-3,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an octa-3,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-3,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-3,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

1-Methyl-2-hydroadenosine

2-(hydroxymethyl)-5-(6-imino-1-methyl-2,3,6,9-tetrahydro-1H-purin-9-yl)oxolane-3,4-diol

C11H17N5O4 (283.1280482)


   

Amonafide

11-amino-3-[2-(dimethylamino)ethyl]-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C16H17N3O2 (283.1320702)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

(2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralin

N,N-dimethyl-5-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine

C18H25N3 (283.204837)


   

Atglistatin

1-[4-(dimethylamino)-[1,1-biphenyl]-3-yl]-3,3-dimethylurea

C17H21N3O (283.1684536)


Atglistatin is a selective adipose triglyceride lipase (ATGL) inhibitor which inhibits lipolysis with an IC50 of 0.7 μM in vitro.

   

Dazmegrel

3-{3-[(1H-imidazol-1-yl)methyl]-2-methyl-1H-indol-1-yl}propanoic acid

C16H17N3O2 (283.1320702)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

Histidinyl-Lysine

6-Amino-2-{[2-amino-1-hydroxy-3-(1H-imidazol-5-yl)propylidene]amino}hexanoate

C12H21N5O3 (283.16443160000006)


   

Tesmilifene

N,N-Diethyl-2-((4-phenylmethyl)phenoxy)-ethanamine hydrochloride

C19H25NO (283.193604)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   
   

Tryptophandehydrobutyrine diketopiperazine

Tryptophandehydrobutyrine diketopiperazine

C16H17N3O2 (283.1320702)


   

2,3-Dimethoxy-6-methyl-5,6,7,8-tetrahydrodibenzo[c,e]azocine

2,3-Dimethoxy-6-methyl-5,6,7,8-tetrahydrodibenzo[c,e]azocine

C18H21NO2 (283.1572206)


   

Coccuvinine

O-Methylcoccuvine

C18H21NO2 (283.1572206)


   
   
   
   
   

Aerocyanidin

(-)-Aerocyanidin

C15H25NO4 (283.178349)


   

3,4-Dihydroxy-5-(3,4-dimethoxyphenyl)-1-methylpyrrolidine-2-methanol

3,4-Dihydroxy-5-(3,4-dimethoxyphenyl)-1-methylpyrrolidine-2-methanol

C14H21NO5 (283.1419656)


   
   
   
   

Ethyl 5-amino-4-cyano-3-methyl-1-(4-methylphenyl)-1H-pyrrole-2-carboxylate

Ethyl 5-amino-4-cyano-3-methyl-1-(4-methylphenyl)-1H-pyrrole-2-carboxylate

C16H17N3O2 (283.1320702)


   
   

N1-(5,6-Dimethyl-2,3-dihydro-1H-benzo[d]imidazol-2-yliden)oct-2-ynamide

N1-(5,6-Dimethyl-2,3-dihydro-1H-benzo[d]imidazol-2-yliden)oct-2-ynamide

C17H21N3O (283.1684536)


   

N-(ortho-methoxybenzyl)-4-ethylamphetamine

N-(ortho-methoxybenzyl)-4-ethylamphetamine

C19H25NO (283.193604)


   

N-Dodecanoyl-DL-homoserine lactone

N-Dodecanoyl-DL-homoserine lactone

C16H29NO3 (283.2147324)


   

3-Methyl-1-[3-(2-hydroxy-3-methyl-3-butenyl)-1H-indol-5-yl]-2-buten-1-one

3-Methyl-1-[3-(2-hydroxy-3-methyl-3-butenyl)-1H-indol-5-yl]-2-buten-1-one

C18H21NO2 (283.1572206)


   

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

C19H25NO (283.193604)


   
   

(2E,4E)-N-(p-hydroxyphenylethyl)-2,4-decadien-9-ynamide|acmelline

(2E,4E)-N-(p-hydroxyphenylethyl)-2,4-decadien-9-ynamide|acmelline

C18H21NO2 (283.1572206)


   

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

C19H25NO (283.193604)


   

2,4-Tetradecadien-8,10-diynoic acid piperidide

2,4-Tetradecadien-8,10-diynoic acid piperidide

C19H25NO (283.193604)


   

2,2-Dimethyl-3-[5-(3-methyl-2-butenoyl)-1H-indol-3-yl]propanal

2,2-Dimethyl-3-[5-(3-methyl-2-butenoyl)-1H-indol-3-yl]propanal

C18H21NO2 (283.1572206)


   

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

C19H25NO (283.193604)


   
   
   
   
   
   
   

1-(2,3-dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione

NCGC00380136-01!1-(2,3-dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione

C15H25NO4 (283.178349)


   

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

NCGC00169940-02!3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

C16H17N3O2 (283.1320702)


   

C12-homoserine lactone

N-Dodecanoyl-DL-homoserine lactone

C16H29NO3 (283.2147324)


CONFIDENCE standard compound; INTERNAL_ID 205

   

N-dodecanoyl-S-homoserine lactone

N-dodecanoyl-S-homoserine lactone

C16H29NO3 (283.2147324)


   

1-(2,3-dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione [IIN-based on: CCMSLIB00000846771]

NCGC00380136-01!1-(2,3-dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione [IIN-based on: CCMSLIB00000846771]

C15H25NO4 (283.178349)


   

1-(2,3-dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione [IIN-based: Match]

NCGC00380136-01!1-(2,3-dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione [IIN-based: Match]

C15H25NO4 (283.178349)


   
   

S-METOLACHLOR

(R)-Metolachlor

C15H22ClNO2 (283.1338982)


CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9430; ORIGINAL_PRECURSOR_SCAN_NO 9428 CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9444; ORIGINAL_PRECURSOR_SCAN_NO 9443 CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9451; ORIGINAL_PRECURSOR_SCAN_NO 9449 CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9483; ORIGINAL_PRECURSOR_SCAN_NO 9478 CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9509; ORIGINAL_PRECURSOR_SCAN_NO 9507 CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9489; ORIGINAL_PRECURSOR_SCAN_NO 9487 DATA_PROCESSING MERGING RMBmix ver. 0.2.7; CONFIDENCE standard compound; INTERNAL_ID 1143; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9489; ORIGINAL_PRECURSOR_SCAN_NO 9487

   

UNII:C19D0413EL

α-Hydroxymetoprolol

C15H25NO4 (283.178349)


   
   
   
   
   
   

Propoxyphene carbinol

[S-(R*,S*)]-alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenylphenethyl alcohol

C19H25NO (283.193604)


   
   
   
   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

C12-HSL

N-[(3S)-tetrahydro-2-oxo-3-furanyl]-dodecanamide

C16H29NO3 (283.2147324)


   

epi-Tumonoic Acid D

epi-Tumonoic Acid D

C16H29NO3 (283.2147324)


   

N-Dealkylatedtolterodine

4-methyl-2-[(1S)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.193604)


   

GLN-His

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-4-carbamoylbutanoic acid

C11H17N5O4 (283.1280482)


   

His-GLN

2-(2-amino-4-carbamoylbutanamido)-3-(1H-imidazol-5-yl)propanoic acid

C11H17N5O4 (283.1280482)


   

His-lys

2-(2,6-diaminohexanamido)-3-(1H-imidazol-5-yl)propanoic acid

C12H21N5O3 (283.16443160000006)


A dipeptide formed from L-histidine and L-lysine residues.

   

His-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-(1H-imidazol-5-yl)propanoic acid

C11H17N5O4 (283.1280482)


   

Lys-his

6-amino-2-[2-amino-3-(1H-imidazol-5-yl)propanamido]hexanoic acid

C12H21N5O3 (283.16443160000006)


   

GGlu-his

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-4-(C-hydroxycarbonimidoyl)butanoic acid

C11H17N5O4 (283.1280482)


   

Cadralazine

N-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}ethoxycarbohydrazonic acid

C12H21N5O3 (283.16443160000006)


C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DB - Hydrazinophthalazine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

2-PHENYL-P-BUTYROPHENETIDIDE

2-PHENYL-P-BUTYROPHENETIDIDE

C18H21NO2 (283.1572206)


   

ammonium dodecylsulfate

ammonium dodecylsulfate

C12H29NO4S (283.1817194)


   

N-(4-METHOXY-2-HYDROXYBENZYLIDENE)-4-N-BUTYLANILINE

N-(4-METHOXY-2-HYDROXYBENZYLIDENE)-4-N-BUTYLANILINE

C18H21NO2 (283.1572206)


   

1-BOC-4-(4-METHOXY-4-OXO-2-BUTENYL)PIPERIDINE

1-BOC-4-(4-METHOXY-4-OXO-2-BUTENYL)PIPERIDINE

C15H25NO4 (283.178349)


   

Drobuline

Drobuline

C19H25NO (283.193604)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

   

1,2-Ethanediamine,N1-(phenylmethyl)-N2-[2-[(phenylmethyl)amino]ethyl]-

1,2-Ethanediamine,N1-(phenylmethyl)-N2-[2-[(phenylmethyl)amino]ethyl]-

C18H25N3 (283.204837)


   

cis-2-Benzylaminomethyl-1-cyclooctanol hydrochloride

cis-2-Benzylaminomethyl-1-cyclooctanol hydrochloride

C16H26ClNO (283.1702816)


   

Naxagolide hydrochloride

ent Naxagolide Hydrochloride

C15H22ClNO2 (283.1338982)


C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

2-amino-1,1-diphenylheptan-1-ol

2-amino-1,1-diphenylheptan-1-ol

C19H25NO (283.193604)


   

N-[5-(2-methylsulfanylethoxy)pyrimidin-2-yl]hexanamide

N-[5-(2-methylsulfanylethoxy)pyrimidin-2-yl]hexanamide

C13H21N3O2S (283.13544060000004)


   

1-Benzyl-[1,4-bipiperidine]-4-carbonitrile

1-Benzyl-[1,4-bipiperidine]-4-carbonitrile

C18H25N3 (283.204837)


   

1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclobutanecarbonitrile

1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclobutanecarbonitrile

C17H22BNO2 (283.1743502)


   

Bemitradine

Bemitradine

C15H17N5O (283.1433032)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

   

6,7-DIMETHOXY-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

6,7-DIMETHOXY-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

C18H21NO2 (283.1572206)


   

(2-(4-METHYL-2-PHENYLPIPERAZIN-1-YL)PYRIDIN-3-YL)METHANOL

(2-(4-METHYL-2-PHENYLPIPERAZIN-1-YL)PYRIDIN-3-YL)METHANOL

C17H21N3O (283.1684536)


   

2-(TERT-BUTOXYCARBONYL)DECAHYDROISOQUINOLINE-6-CARBOXYLIC ACID

2-(TERT-BUTOXYCARBONYL)DECAHYDROISOQUINOLINE-6-CARBOXYLIC ACID

C15H25NO4 (283.178349)


   
   

3-BENZYLPIPERIDINE-3-ETHYLCARBOXYLATE HYDROCHLORIDE

3-BENZYLPIPERIDINE-3-ETHYLCARBOXYLATE HYDROCHLORIDE

C15H22ClNO2 (283.1338982)


   

5-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

5-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

C14H25NO3Si (283.160362)


   

(3S,4S)-METHYL 1-METHYL-4-(NAPHTHALEN-2-YL)PIPERIDINE-3-CARBOXYLATE

(3S,4S)-METHYL 1-METHYL-4-(NAPHTHALEN-2-YL)PIPERIDINE-3-CARBOXYLATE

C18H21NO2 (283.1572206)


   

5,7-Dihydro-7,7-dimethyl-indeno[2,1-b]carbazole

5,7-Dihydro-7,7-dimethyl-indeno[2,1-b]carbazole

C21H17N (283.1360922)


   

1-Tert-Butyl 4-Methyl 4-Allylpiperidine-1,4-Dicarboxylate

1-Tert-Butyl 4-Methyl 4-Allylpiperidine-1,4-Dicarboxylate

C15H25NO4 (283.178349)


   

tert-butyl 1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopent-3-ene-1-carboxylate

tert-butyl 1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopent-3-ene-1-carboxylate

C15H25NO4 (283.178349)


   

Benzeneacetic acid, a-[[(phenylmethyl)amino]methyl]-,ethyl ester

Benzeneacetic acid, a-[[(phenylmethyl)amino]methyl]-,ethyl ester

C18H21NO2 (283.1572206)


   

6-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

6-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

C14H25NO3Si (283.160362)


   

9-(1-benzothiophen-2-yl)-3-azaspiro[5.5]undec-9-ene

9-(1-benzothiophen-2-yl)-3-azaspiro[5.5]undec-9-ene

C18H21NS (283.1394626)


   

Boc-L-(π-Me)-His-OMe

Boc-L-(π-Me)-His-OMe

C13H21N3O4 (283.1531986)


   

1-[2-(4-METHOXY-PHENOXY)-ETHYL]-1H-BENZOIMIDAZOL-2-YLAMINE

1-[2-(4-METHOXY-PHENOXY)-ETHYL]-1H-BENZOIMIDAZOL-2-YLAMINE

C16H17N3O2 (283.1320702)


   

3-AMINO-4-CHLOROBENZOIC ACID OCTYL ESTER

3-AMINO-4-CHLOROBENZOIC ACID OCTYL ESTER

C15H22ClNO2 (283.1338982)


   

Acetanilide,2,2-iminobis- (8CI)

Acetanilide,2,2-iminobis- (8CI)

C16H17N3O2 (283.1320702)


   

4-Aminobenzo-15-crown-5

4-Aminobenzo-15-crown-5

C14H21NO5 (283.1419656)


   

Alentemol

Alentemol

C19H25NO (283.193604)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

Uracil,6-amino-5-(2-diethylaminoacetamido)-1,3-dimethyl- (6CI)

Uracil,6-amino-5-(2-diethylaminoacetamido)-1,3-dimethyl- (6CI)

C12H21N5O3 (283.16443160000006)


   

Tedatioxetine

4-[2-(4-methylphenyl)sulfanylphenyl]piperidine

C18H21NS (283.1394626)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

3-[2-(2-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDIN-6-YL]-PROPAN-1-OL

3-[2-(2-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDIN-6-YL]-PROPAN-1-OL

C16H17N3O2 (283.1320702)


   

1-(2-NITROBENZYL)PIPERAZINEDIHYDROCHLORIDE

1-(2-NITROBENZYL)PIPERAZINEDIHYDROCHLORIDE

C16H17N3O2 (283.1320702)


   

(4-(Benzyl(ethyl)carbamoyl)phenyl)boronic acid

(4-(Benzyl(ethyl)carbamoyl)phenyl)boronic acid

C16H18BNO3 (283.1379668)


   
   
   
   

Methyl 1-Boc-3-allylpiperidine-3-carboxylate

Methyl 1-Boc-3-allylpiperidine-3-carboxylate

C15H25NO4 (283.178349)


   

(3S,5S)-5-((1S,3S)-1-AZIDO-4-HYDROXY-3-ISOPROPYLBUTYL)-DIHYDRO-3-ISOPROPYLFURAN-2(3H)-ONE

(3S,5S)-5-((1S,3S)-1-AZIDO-4-HYDROXY-3-ISOPROPYLBUTYL)-DIHYDRO-3-ISOPROPYLFURAN-2(3H)-ONE

C14H25N3O3 (283.189582)


   

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

C17H30ClN (283.20666500000004)


   
   

N,N,N-Tripropyl-1-propanaminium hydrogen sulfate

N,N,N-Tripropyl-1-propanaminium hydrogen sulfate

C12H29NO4S (283.1817194)


   

2,4,6-TRIISOPROPYLBENZENESULFONAMIDE

2,4,6-TRIISOPROPYLBENZENESULFONAMIDE

C15H25NO2S (283.160591)


   
   

2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol

2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol

C17H21N3O (283.1684536)


   

Beloxamide

N-phenylmethoxy-N-(3-phenylpropyl)acetamide

C18H21NO2 (283.1572206)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   

ethyl 2-(dibenzylamino)acetate

ethyl 2-(dibenzylamino)acetate

C18H21NO2 (283.1572206)


   

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

C19H25NO (283.193604)


   

9-(2,2-DIETHOXY-ETHYL)-9H-CARBAZOLE

9-(2,2-DIETHOXY-ETHYL)-9H-CARBAZOLE

C18H21NO2 (283.1572206)


   

(S)-Ethyl 1-(3,3-dimethyl-2-oxopentanoyl)piperidine-2-carboxylate

(S)-Ethyl 1-(3,3-dimethyl-2-oxopentanoyl)piperidine-2-carboxylate

C15H25NO4 (283.178349)


   

(1S,2S)-2-(Diphenylphosphino)cyclohexanamine

(1S,2S)-2-(Diphenylphosphino)cyclohexanamine

C18H22NP (283.1489782)


   

2-Methyl-2-propanyl 3,3-dimethyl-1-oxo-2-oxa-7-azaspiro[4.5]decan e-7-carboxylate

2-Methyl-2-propanyl 3,3-dimethyl-1-oxo-2-oxa-7-azaspiro[4.5]decan e-7-carboxylate

C15H25NO4 (283.178349)


   

2-Methyl-2-propanyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-car boxylate

2-Methyl-2-propanyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-car boxylate

C14H21NO5 (283.1419656)


   

1-benzyl-3-(2-methoxyphenyl)pyrrolidin-3-ol

1-benzyl-3-(2-methoxyphenyl)pyrrolidin-3-ol

C18H21NO2 (283.1572206)


   

Benzenepropanenitrile, a,a-diphenyl-

Benzenepropanenitrile, a,a-diphenyl-

C21H17N (283.1360922)


   

Benzenepropanenitrile, b,b-diphenyl-

Benzenepropanenitrile, b,b-diphenyl-

C21H17N (283.1360922)


   

Ethyl (8-ethyl-8-methyl-9-oxa-2-azaspiro[5.5]undec-2-yl)acetate

Ethyl (8-ethyl-8-methyl-9-oxa-2-azaspiro[5.5]undec-2-yl)acetate

C16H29NO3 (283.2147324)


   

2-amino-n-furan-2-ylmethyl-3-(1h-indol-3-yl)-propionamide

2-amino-n-furan-2-ylmethyl-3-(1h-indol-3-yl)-propionamide

C16H17N3O2 (283.1320702)


   

p-methoxycinnamic acid, compound with 2,2-iminodiethanol (1:1)

p-methoxycinnamic acid, compound with 2,2-iminodiethanol (1:1)

C14H21NO5 (283.1419656)


   

4-AMINO-1-TERT-BUTYL-3-(2-HYDROXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE

4-AMINO-1-TERT-BUTYL-3-(2-HYDROXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE

C15H17N5O (283.1433032)


   

1-(4-Aminophenyl)-4-(4-methoxyphenyl)piperazine

1-(4-Aminophenyl)-4-(4-methoxyphenyl)piperazine

C17H21N3O (283.1684536)


   

Meperidine Hydrochloride

Meperidine Hydrochloride

C15H22ClNO2 (283.1338982)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

N-(1-Methylazepan-4-yl)benzohydrazide

N-(1-Methylazepan-4-yl)benzohydrazide

C14H22ClN3O (283.1451312)


   

methyl 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.2]octane-1-carboxylate

methyl 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.2]octane-1-carboxylate

C15H25NO4 (283.178349)


   

N-cyclopentyl-5-(4-methoxyphenyl)-2-methylpyrimidin-4-amine

N-cyclopentyl-5-(4-methoxyphenyl)-2-methylpyrimidin-4-amine

C17H21N3O (283.1684536)


   

(E)-tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate

(E)-tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate

C14H26BNO4 (283.1954786)


   

COUMARIN 480 D DYE CONTENT 99

COUMARIN 480 D DYE CONTENT 99

C18H21NO2 (283.1572206)


   

2-Piperidineacetic acid, α-phenyl-, ethyl ester, hydrochloride (), (αS,2S)

2-Piperidineacetic acid, α-phenyl-, ethyl ester, hydrochloride (), (αS,2S)

C15H22ClNO2 (283.1338982)


   

2-DIISOBUTYLCARBAMOYL-CYCLOHEXANECARBOXYLIC ACID

2-DIISOBUTYLCARBAMOYL-CYCLOHEXANECARBOXYLIC ACID

C16H29NO3 (283.2147324)


   

8,8-dimethyl-5,8-dihydroindeno[2,1-c]carbazole

8,8-dimethyl-5,8-dihydroindeno[2,1-c]carbazole

C21H17N (283.1360922)


   

2-[(tert-butoxy)carbonyl]-2-azaspiro[4.5]decane-7-carboxylic acid

2-[(tert-butoxy)carbonyl]-2-azaspiro[4.5]decane-7-carboxylic acid

C15H25NO4 (283.178349)


   

ETHYL (2Z)-3-AMINO-4,4,4-TRICHLORO-2-CYANOBUT-2-ENOATE

ETHYL (2Z)-3-AMINO-4,4,4-TRICHLORO-2-CYANOBUT-2-ENOATE

C15H25NO4 (283.178349)


   

(E)-tert-Butyl 4-(2-ethoxy-2-oxoethylidene)azepane-1-carboxylate

(E)-tert-Butyl 4-(2-ethoxy-2-oxoethylidene)azepane-1-carboxylate

C15H25NO4 (283.178349)


   

ethyl 6-{[(tert-butoxy)carbonyl]amino}spiro[3.3]heptane-2-carboxylate

ethyl 6-{[(tert-butoxy)carbonyl]amino}spiro[3.3]heptane-2-carboxylate

C15H25NO4 (283.178349)


   

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

C19H25NO (283.193604)


   

1-[2-AMINO-4-(PHENYLMETHOXY)-3-PROPYLPHENYL]-ETHANONE

1-[2-AMINO-4-(PHENYLMETHOXY)-3-PROPYLPHENYL]-ETHANONE

C18H21NO2 (283.1572206)


   

benzyldimethyloctylammonium chloride

benzyldimethyloctylammonium chloride

C17H30ClN (283.20666500000004)


   

Boronic acid, B-​[3-​fluoro-​4-​[3-​(4-​morpholinyl)​propoxy]​phenyl]​-

Boronic acid, B-​[3-​fluoro-​4-​[3-​(4-​morpholinyl)​propoxy]​phenyl]​-

C13H19BFNO4 (283.1391096)


   

Oxtriphylline

choline thieophyllinate

C12H21N5O3 (283.16443160000006)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

levallorphan hydrogen tartrate

levallorphan hydrogen tartrate

C19H25NO (283.193604)


   

Tripiperidinophosphine

Tripiperidinophosphine

C15H30N3P (283.217723)


   

3-trimethylsilylmethyl-4-trimethylsilyl-n-tert-butylcrotonaldimine

3-trimethylsilylmethyl-4-trimethylsilyl-n-tert-butylcrotonaldimine

C15H33NSi2 (283.21514179999997)


   

(4R,4aR,7aS,12bS)-3,7-dimethyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol

(4R,4aR,7aS,12bS)-3,7-dimethyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol

C18H21NO2 (283.1572206)


   

ethyl 2-phenyl-2-piperidin-2-ylacetate,hydrochloride

ethyl 2-phenyl-2-piperidin-2-ylacetate,hydrochloride

C15H22ClNO2 (283.1338982)


   

4-cyano-4-ethyl-p,p-terphenyl

4-cyano-4-ethyl-p,p-terphenyl

C21H17N (283.1360922)


   

N-Benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

N-Benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

C18H21NO2 (283.1572206)


   

(3S,4R)-1-tert-Butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carboxylic acid

(3S,4R)-1-tert-Butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carboxylic acid

C15H19F2NO2 (283.1383778)


   

6-Benzyloxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline

6-Benzyloxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline

C18H21NO2 (283.1572206)


   

Nerispirdine

Nerispirdine

C17H18FN3 (283.14846800000004)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

2-[4-(Dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium

2-[4-(Dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium

C17H19N2S+ (283.1268874)


   

2-Methoxy-6-[[(1-methylbenzimidazol-2-yl)amino]methyl]phenol

2-Methoxy-6-[[(1-methylbenzimidazol-2-yl)amino]methyl]phenol

C16H17N3O2 (283.1320702)


   

5-methyl-8-(tetrahydro-2-furanylmethyl)-7,8-dihydro-6H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine-3-carbonitrile

5-methyl-8-(tetrahydro-2-furanylmethyl)-7,8-dihydro-6H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine-3-carbonitrile

C15H17N5O (283.1433032)


   

4-Phenyl-2-(piperidin-1-yl)pyrimidine-5-carboxylic acid

4-Phenyl-2-(piperidin-1-yl)pyrimidine-5-carboxylic acid

C16H17N3O2 (283.1320702)


   

5-Methoxy-2-[[(1-methyl-2-benzimidazolyl)amino]methyl]phenol

5-Methoxy-2-[[(1-methyl-2-benzimidazolyl)amino]methyl]phenol

C16H17N3O2 (283.1320702)


   

Prolyl-prolyl-alanine

Prolyl-prolyl-alanine

C13H21N3O4 (283.1531986)


   

L-Alanyl-L-histidylglycine

L-Alanyl-L-histidylglycine

C11H17N5O4 (283.1280482)


   

3-Oxo-N-[(3S)-2-oxooxolan-3-yl]undecanamide

3-Oxo-N-[(3S)-2-oxooxolan-3-yl]undecanamide

C15H25NO4 (283.178349)


   

2-Methyl-3,7-diphenyl-1H-indole

2-Methyl-3,7-diphenyl-1H-indole

C21H17N (283.1360922)


   

1-(2-(3-Cyclohexenyl)ethyl)silatrane

1-(2-(3-Cyclohexenyl)ethyl)silatrane

C14H25NO3Si (283.160362)


   

3-(4-Amino-1-tert-butyl-1H-pyrazolo[3,4-D]pyrimidin-3-YL)phenol

3-(4-Amino-1-tert-butyl-1H-pyrazolo[3,4-D]pyrimidin-3-YL)phenol

C15H17N5O (283.1433032)


   

Amonafide

Amonafide

C16H17N3O2 (283.1320702)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

Dazmegrel

Dazmegrel

C16H17N3O2 (283.1320702)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

C16H17N3O2 (283.1320702)


   

Sdccgsbi-0050749.P002

Sdccgsbi-0050749.P002

C19H25NO (283.193604)


   

N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid

N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid

C15H25NO4 (283.178349)


   

3,4-Dihydroxybenzoate-spermidine

3,4-Dihydroxybenzoate-spermidine

C14H25N3O3+2 (283.189582)


   

Octa-2,6-dienoylcarnitine

Octa-2,6-dienoylcarnitine

C15H25NO4 (283.178349)


   

Octa-3,6-dienoylcarnitine

Octa-3,6-dienoylcarnitine

C15H25NO4 (283.178349)


   

Octa-2,5-dienoylcarnitine

Octa-2,5-dienoylcarnitine

C15H25NO4 (283.178349)


   

Octa-2,4-dienoylcarnitine

Octa-2,4-dienoylcarnitine

C15H25NO4 (283.178349)


   

Octa-3,5-dienoylcarnitine

Octa-3,5-dienoylcarnitine

C15H25NO4 (283.178349)


   

(4Z,6Z)-Octa-4,6-dienoylcarnitine

(4Z,6Z)-Octa-4,6-dienoylcarnitine

C15H25NO4 (283.178349)


   

[(8R)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2R)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate

[(8R)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2R)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO4 (283.178349)


   

1-[4-(Diethylamino)phenyl]-3-phenylurea

1-[4-(Diethylamino)phenyl]-3-phenylurea

C17H21N3O (283.1684536)


   

Ala-Gly-His

Ala-Gly-His

C11H17N5O4 (283.1280482)


A tripeptide composed of L-alanine, glycine, and L-histidine joined in sequence by peptide linkages.

   

N-tert-butyl-7,7-dimethyl-2-oxo-1,8-dioxaspiro[4.5]decane-4-carboxamide

N-tert-butyl-7,7-dimethyl-2-oxo-1,8-dioxaspiro[4.5]decane-4-carboxamide

C15H25NO4 (283.178349)


   
   

1-(1-L-Alanyl-L-prolyl)-L-proline

1-(1-L-Alanyl-L-prolyl)-L-proline

C13H21N3O4 (283.1531986)


   

1-Methyl-2-hydroadenosine

1-Methyl-2-hydroadenosine

C11H17N5O4 (283.1280482)


   

Glycyl-alanyl-histidine

Glycyl-alanyl-histidine

C11H17N5O4 (283.1280482)


   

N-methyl-N-phenylcarbamic acid (4-tert-butylphenyl) ester

N-methyl-N-phenylcarbamic acid (4-tert-butylphenyl) ester

C18H21NO2 (283.1572206)


   

3-(5-Tert-butyl-1,2,4-oxadiazol-3-ylidene)-7-methyl-2-quinolinone

3-(5-Tert-butyl-1,2,4-oxadiazol-3-ylidene)-7-methyl-2-quinolinone

C16H17N3O2 (283.1320702)


   

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

C19H25NO (283.193604)


   

1-(1-Benzotriazolyl)-3-(2-methylphenoxy)-2-propanol

1-(1-Benzotriazolyl)-3-(2-methylphenoxy)-2-propanol

C16H17N3O2 (283.1320702)


   

2-Amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester

2-Amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester

C16H17N3O2 (283.1320702)


   

1-(2,3-Dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione

1-(2,3-Dihydropyrrol-1-yl)-8,9-dihydroxy-2-methyldecane-1,3-dione

C15H25NO4 (283.178349)


   

11-Cyclohexyl-12-oxa-1,8,11-triazatetracyclo[7.6.0.02,7.010,14]pentadeca-2,4,6,8-tetraene

11-Cyclohexyl-12-oxa-1,8,11-triazatetracyclo[7.6.0.02,7.010,14]pentadeca-2,4,6,8-tetraene

C17H21N3O (283.1684536)


   
   
   
   

N-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-yl)-2-(propan-2-ylamino)acetamide

N-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-yl)-2-(propan-2-ylamino)acetamide

C17H21N3O (283.1684536)


   

1-(2,5-Dimethoxyphenyl)-1-[(trimethylsilyl)oxy]propan-2-amine

1-(2,5-Dimethoxyphenyl)-1-[(trimethylsilyl)oxy]propan-2-amine

C14H25NO3Si (283.160362)


   
   

[(2R,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

4-[acetyl(methyl)amino]-N-(2-aminophenyl)benzamide

4-[acetyl(methyl)amino]-N-(2-aminophenyl)benzamide

C16H17N3O2 (283.1320702)


   

[(2S,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2R,3R,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2S,3S,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2R,3R,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   
   

(E)-Delta-oxomycolate

(E)-Delta-oxomycolate

C16H27O4- (283.1909242)


   

2-[(2S)-2-[(2R)-2-morpholinyl]-2-phenylethyl]phenol

2-[(2S)-2-[(2R)-2-morpholinyl]-2-phenylethyl]phenol

C18H21NO2 (283.1572206)


   

4-Spiro-(N-methylpiperidyl)-2,2-dimethyl-1,2,3,4-tetrahydro-gamma-carboline

4-Spiro-(N-methylpiperidyl)-2,2-dimethyl-1,2,3,4-tetrahydro-gamma-carboline

C18H25N3 (283.204837)


   

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]acetamide

C16H29NO3 (283.2147324)


   

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]propanamide

C16H29NO3 (283.2147324)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]butanamide

C16H29NO3 (283.2147324)


   

3-(1-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(1-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C18H25N3 (283.204837)


   

3-(3-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(3-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C18H25N3 (283.204837)


   

levallorphan

levallorphan

C19H25NO (283.193604)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   
   

Tesmilifene

Tesmilifene

C19H25NO (283.193604)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

metolachlor

metolachlor [ANSI, WSSA]

C15H22ClNO2 (283.1338982)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Amabiline

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1H-pyrrolidizin-7-yl)methyl ester

C15H25NO4 (283.178349)


A carboxylic ester obtained by formal condensation of the carboxy group of (2S,3S)-2,3-dihydroxy-2-isopropylbutanoic acid with the hydroxy group of (7aS)-2,3,5,7a-tetrahydropyrrolizin-7-ylmethanol.

   

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

C19H25NO (283.193604)


   
   
   
   

Histidinyl-Gamma-glutamate

Histidinyl-Gamma-glutamate

C11H17N5O4 (283.1280482)


   

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

C19H25NO (283.193604)


   
   
   

N-Dodecanoyl-homoserine lactone

N-Dodecanoyl-homoserine lactone

C16H29NO3 (283.2147324)


   
   
   
   
   
   
   

AS19

AS19

C18H25N3 (283.204837)


AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM. AS19 is selective for 5-HT7 over 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT5A receptors (Kis = 89.7 nM, 490 nM, 6.6 nM and 98.5 nM, respectively). AS19 enhances memory consolidation and reverses Scopolamine- or Dizocilpine-induced amnesia[1][2][3].

   

(2s)-1-[(2r)-2-methyldecanoyl]pyrrolidine-2-carboxylic acid

(2s)-1-[(2r)-2-methyldecanoyl]pyrrolidine-2-carboxylic acid

C16H29NO3 (283.2147324)


   

4,5-dimethoxy-9-methyl-9-azatricyclo[10.4.0.0²,⁷]hexadeca-1(16),2(7),3,5,12,14-hexaene

4,5-dimethoxy-9-methyl-9-azatricyclo[10.4.0.0²,⁷]hexadeca-1(16),2(7),3,5,12,14-hexaene

C18H21NO2 (283.1572206)


   

(2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-(3h-imidazol-4-yl)propanoic acid

(2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-(3h-imidazol-4-yl)propanoic acid

C11H17N5O4 (283.1280482)


   

2-(n-hydroxyimino)-3-[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]propanamide

2-(n-hydroxyimino)-3-[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]propanamide

C16H17N3O2 (283.1320702)


   

2-[(4e,6z)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(4e,6z)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572206)


   

(7ar)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(7ar)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO4 (283.178349)


   

1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

C16H29NO3 (283.2147324)


   

2-[(3z,5z,7s)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

2-[(3z,5z,7s)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572206)


   

(9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline

(9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline

C18H21NO2 (283.1572206)


   

(2r)-2-(dimethylamino)-4-(4-hydroxy-3,5-dimethoxyphenyl)butanoic acid

(2r)-2-(dimethylamino)-4-(4-hydroxy-3,5-dimethoxyphenyl)butanoic acid

C14H21NO5 (283.1419656)


   

2-ethyl-3-[2-(1h-indol-3-yl)ethyl]-2,5-dimethylimidazol-4-one

2-ethyl-3-[2-(1h-indol-3-yl)ethyl]-2,5-dimethylimidazol-4-one

C17H21N3O (283.1684536)


   

2-[(3z,5e,7r)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

2-[(3z,5e,7r)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572206)


   

2-[(3s,4e,6e)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(3s,4e,6e)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572206)


   

n-[2-(4-hydroxyphenyl)ethyl]deca-2,4-dien-9-ynimidic acid

n-[2-(4-hydroxyphenyl)ethyl]deca-2,4-dien-9-ynimidic acid

C18H21NO2 (283.1572206)


   

1-(2-methyldecanoyl)pyrrolidine-2-carboxylic acid

1-(2-methyldecanoyl)pyrrolidine-2-carboxylic acid

C16H29NO3 (283.2147324)